China's Xi Orders Probe of Vaccine Makers After Violation Found

The transcript discusses a fraudulent data incident involving Chengcheng biotechnology company related to rabies vaccines, leading to increased regulatory oversight in the Chinese vaccine industry. This incident is not isolated, as it feeds into existing consumer concerns about product safety in China, including past scandals with infant formula. The vaccine business, previously lucrative, is now facing stock price declines due to these concerns. Despite being somewhat insulated from the US-China trade war, the industry is experiencing increased scrutiny and uncertainty about its future.

What was the main issue with Chengcheng Biotechnology Company?

• They were involved in a trade war.

• They submitted fraudulent data related to rabies vaccines.

• They produced ineffective vaccines.

• They refused to comply with government regulations.

How has the vaccine scandal affected the stock prices of vaccine makers in China?

• Stock prices have increased by 10%.

• Stock prices have remained stable.

• Stock prices have tumbled by the 10% limit.

• Stock prices have decreased by 5%.

What was the expected growth of the vaccine market in China before the scandal?

• It was expected to remain the same.

• It was expected to decrease.

• It was expected to double.

• It was expected to triple.

Why was the vaccine industry considered insulated from the US-China trade war?

• It was not related to health.

• It was not affected by other sectors.

• It was a new industry.

• It had no international involvement.

What is the current concern regarding the vaccine industry in China?

• There is a lack of demand.

• There is a shortage of raw materials.

• There is an increase in international competition.

• There is greater oversight and worry about the industry's direction.